Comprehensive ctDNA monitoring provides early signal of clinical benefit with a novel personalized neoantigen directed immunotherapy for late-stage cancer patients Meeting Abstract
| Authors: | Schenck, D.; Zhou, R.; Mantilla, A.; Spiro, O.; Patch, T.; Johnson, A.; Gomez, D. N.; Henick, B. S.; Liao, C. Y.; Roychowdhury, S.; Maron, S.; Solomon, B.; Spira, A. I.; Catenacci, D. V.; Fergusson, A. R.; Rousseau, R. F.; Jooss, K.; Davis, M. J. |
| Abstract Title: | Comprehensive ctDNA monitoring provides early signal of clinical benefit with a novel personalized neoantigen directed immunotherapy for late-stage cancer patients |
| Meeting Title: | 113th Annual Meeting of the American Association for Cancer Research (AACR) |
| Journal Title: | Cancer Research |
| Volume: | 82 |
| Issue: | 12 Suppl. |
| Meeting Dates: | 2022 Apr 8-13 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2022-06-15 |
| Language: | English |
| ACCESSION: | WOS:000892509505184 |
| PROVIDER: | wos |
| DOI: | 10.1158/1538-7445.AM2022-1238 |
| Notes: | Meeting Abstract: 1238 -- Source: Wos |
